Safety and efficacy of weekly somapacitan for growth hormone deficiency in children: A 72-week observational study

Abdulmoein E. Al-Agha; Hasan M. Aljefri; Shahd E. Kafi; Aliaa S. Alamri; Abdullah A. Alghamdi

doi:10.15537/smj.2025.46.3.20240937

Article Information

vol. 46 no. 3 269-273

DOI

https://doi.org/10.15537/smj.2025.46.3.20240937

Published By

Saudi Medical Journal

Online ISSN

1658-3175

History

Received October 31, 2024
Accepted February 4, 2025
Published online March 17, 2025.

Copyright: © Saudi Medical Journal This is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.

Author Information

Abdulmoein E. Al-Agha, DCH, FRCPCH ⇑,
Hasan M. Aljefri, MBBS, MD,
Shahd E. Kafi, MBBS, SB-Peds,
Aliaa S. Alamri, MBBS and
Abdullah A. Alghamdi, MBBS

From the Department of Pediatric (Al-Agha, Aljefri, Kafi, Alamri); and from the Department of Community Medicine (Alghamdi), King Abdulaziz University Hospital, Jeddah, Kingdom of Saudi Arabia.

Address correspondence and reprint request to: Dr. Abdulmoein E. Al-Agha, Pediatric Department, King Abdulaziz University Hospital, Jeddah, Kingdom of Saudi Arabia. E-mail: aagha{at}kau.edu.sa

View Full Text